FDA Clears AMAG’s Anemia Drug Manufacturing Facility

AMAG Pharmaceuticals Inc said the U.S. health regulator informed it that the deficiencies noted at a facility manufacturing its experimental anemia drug have been adequately addressed, driving its shares up 17 percent after the bell.
CNBC